Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Pharmacists and Regulatory Science.

Masada M.

Yakugaku Zasshi. 2017;137(4):443-445. doi: 10.1248/yakushi.16-00244-5. Review. Japanese.

2.

Detection of pharmaceuticals and phytochemicals together with their metabolites in hospital effluents in Japan, and their contribution to sewage treatment plant influents.

Azuma T, Arima N, Tsukada A, Hirami S, Matsuoka R, Moriwake R, Ishiuchi H, Inoyama T, Teranishi Y, Yamaoka M, Mino Y, Hayashi T, Fujita Y, Masada M.

Sci Total Environ. 2016 Apr 1;548-549:189-197. doi: 10.1016/j.scitotenv.2015.12.157. Epub 2016 Jan 21.

PMID:
26802347
3.

The Inhibitory Effect of Ciprofloxacin on the β-Glucuronidase-mediated Deconjugation of the Irinotecan Metabolite SN-38-G.

Kodawara T, Higashi T, Negoro Y, Kamitani Y, Igarashi T, Watanabe K, Tsukamoto H, Yano R, Masada M, Iwasaki H, Nakamura T.

Basic Clin Pharmacol Toxicol. 2016 May;118(5):333-7. doi: 10.1111/bcpt.12511. Epub 2015 Dec 2.

4.

Variations in the Blood Phenytoin Levels during Long-Term Combined Treatment with S-1 and Phenytoin.

Negoro Y, Higashi T, Matsuoka H, Watanabe K, Igarashi T, Kayano Y, Yano R, Nakamura T, Masada M.

Case Rep Oncol. 2014 Sep 26;7(3):656-61. doi: 10.1159/000368077. eCollection 2014 Sep-Dec.

5.

Clinical effect of a multidisciplinary team approach to the initial treatment of patients with hospital-acquired bloodstream infections at a Japanese university hospital.

Tsukamoto H, Higashi T, Nakamura T, Yano R, Hida Y, Muroi Y, Ikegaya S, Iwasaki H, Masada M.

Am J Infect Control. 2014 Sep;42(9):970-5. doi: 10.1016/j.ajic.2014.05.033.

PMID:
25179328
6.

Inhibitory effect of ciprofloxacin on β-glucuronidase-mediated deconjugation of mycophenolic acid glucuronide.

Kodawara T, Masuda S, Yano Y, Matsubara K, Nakamura T, Masada M.

Biopharm Drug Dispos. 2014 Jul;35(5):275-83. doi: 10.1002/bdd.1894. Epub 2014 Mar 20.

PMID:
24615849
7.

Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats.

Okamura T, Tawa M, Geddawy A, Shimosato T, Iwasaki H, Shintaku H, Yoshida Y, Masada M, Shinozaki K, Imamura T.

J Pharmacol Sci. 2014;124(1):76-85. Epub 2013 Dec 27.

8.

[Possible predictors of discontinuation of basal-flow of postoperative patient-controlled analgesia].

Masada M, Inoue S, Nishimura T, Okamoto A, Tanaka Y, Kawaguchi M, Furuya H.

Masui. 2013 Oct;62(10):1166-72. Japanese.

PMID:
24228448
9.

Long-term outcomes of coil packing for visceral aneurysms: correlation between packing density and incidence of coil compaction or recanalization.

Yasumoto T, Osuga K, Yamamoto H, Ono Y, Masada M, Mikami K, Kanamori D, Nakamura M, Tanaka K, Nakazawa T, Higashihara H, Maeda N, Tomiyama N.

J Vasc Interv Radiol. 2013 Dec;24(12):1798-807. doi: 10.1016/j.jvir.2013.04.030. Epub 2013 Jun 27.

PMID:
23810652
10.

Application of hospital preparations for cancer treatment, and an approach toward their commercialization.

Watanabe K, Goto N, Nakamura T, Masada M.

Biol Pharm Bull. 2013;36(5):719-22.

11.

Predictors of response of patients with solid tumors to granulocyte colony-stimulating factor.

Ohnaka H, Tsukamoto H, Nakamura T, Yano R, Watanabe K, Igarashi T, Goto N, Masada M.

Int J Clin Pharm. 2013 Feb;35(1):45-50. doi: 10.1007/s11096-012-9703-6. Epub 2012 Sep 26.

PMID:
23011270
12.

Angiotensin II receptor blockade reduces salt sensitivity of blood pressure through restoration of renal nitric oxide synthesis in patients with diabetic nephropathy.

Imanishi M, Okada N, Konishi Y, Morikawa T, Maeda I, Kitabayashi C, Masada M, Shirahashi N, Wilcox CS, Nishiyama A.

J Renin Angiotensin Aldosterone Syst. 2013 Mar;14(1):67-73. doi: 10.1177/1470320312454764. Epub 2012 Aug 2.

PMID:
22859713
13.

Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis.

Yamamoto H, Yamada T, Sakashita M, Kubo S, Susuki D, Tokunaga T, Ogi K, Terasawa Y, Yamashita S, Kayano Y, Masada M, Kimura Y, Fujieda S.

Allergy Asthma Proc. 2012 Mar-Apr;33(2):e17-22. doi: 10.2500/aap.2012.33.3514.

PMID:
22525385
14.

Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis.

Yamada T, Yamamoto H, Kubo S, Sakashita M, Tokunaga T, Susuki D, Narita N, Ogi K, Kanno M, Yamashita S, Terasawa Y, Kayano Y, Masada M, Fujieda S.

Allergy Asthma Proc. 2012 Mar-Apr;33(2):e9-16. doi: 10.2500/aap.2012.33.3509.

PMID:
22525384
15.

Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials.

Yano R, Konno A, Watanabe K, Tsukamoto H, Kayano Y, Ohnaka H, Goto N, Nakamura T, Masada M.

Int J Clin Oncol. 2013 Feb;18(1):96-104. doi: 10.1007/s10147-011-0349-5. Epub 2011 Nov 18.

PMID:
22095245
16.

Transient elevation of international normalized ratio during cisplatin-based chemotherapy in patients who are taking warfarin.

Yano R, Kurokawa T, Tsuyoshi H, Shinagawa A, Sawamura Y, Matsunaga A, Nakamura T, Yoshida Y, Yoneda M, Kotsuji F, Masada M.

Ann Pharmacother. 2011 Oct;45(10):e55. doi: 10.1345/aph.1Q290. Epub 2011 Aug 31.

PMID:
21881031
17.

Cis-acting mutation and duplication: History of molecular evolution in a P450 haplotype responsible for insecticide resistance in Culex quinquefasciatus.

Itokawa K, Komagata O, Kasai S, Masada M, Tomita T.

Insect Biochem Mol Biol. 2011 Jul;41(7):503-12. doi: 10.1016/j.ibmb.2011.04.002. Epub 2011 Apr 23.

PMID:
21540111
18.

Genomic structures of Cyp9m10 in pyrethroid resistant and susceptible strains of Culex quinquefasciatus.

Itokawa K, Komagata O, Kasai S, Okamura Y, Masada M, Tomita T.

Insect Biochem Mol Biol. 2010 Sep;40(9):631-40. doi: 10.1016/j.ibmb.2010.06.001. Epub 2010 Jun 18.

PMID:
20600899
19.

Evaluation of potential interaction between vinorelbine and clarithromycin.

Yano R, Tani D, Watanabe K, Tsukamoto H, Igarashi T, Nakamura T, Masada M.

Ann Pharmacother. 2009 Mar;43(3):453-8. doi: 10.1345/aph.1L432. Epub 2009 Mar 3.

PMID:
19261952
20.

Variability in teicoplanin protein binding and its prediction using serum albumin concentrations.

Yano R, Nakamura T, Tsukamoto H, Igarashi T, Goto N, Wakiya Y, Masada M.

Ther Drug Monit. 2007 Aug;29(4):399-403.

PMID:
17667792
21.

Pitavastatin restores vascular dysfunction in insulin-resistant state by inhibiting NAD(P)H oxidase activity and uncoupled endothelial nitric oxide synthase-dependent superoxide production.

Shinozaki K, Nishio Y, Ayajiki K, Yoshida Y, Masada M, Kashiwagi A, Okamura T.

J Cardiovasc Pharmacol. 2007 Mar;49(3):122-30.

PMID:
17414223
22.

Decrease in tetrahydrobiopterin as a possible cause of nephropathy in type II diabetic rats.

Okumura M, Masada M, Yoshida Y, Shintaku H, Hosoi M, Okada N, Konishi Y, Morikawa T, Miura K, Imanishi M.

Kidney Int. 2006 Aug;70(3):471-6. Epub 2006 Jun 14.

23.

Supplement of tetrahydrobiopterin by a gene transfer of GTP cyclohydrolase I cDNA improves vascular dysfunction in insulin-resistant rats.

Shinozaki K, Nishio Y, Yoshida Y, Koya D, Ayajiki K, Masada M, Kashiwagi A, Okamura T.

J Cardiovasc Pharmacol. 2005 Oct;46(4):505-12.

PMID:
16160605
24.

Malfunction of vascular control in lifestyle-related diseases: mechanisms underlying endothelial dysfunction in the insulin-resistant state.

Shinozaki K, Ayajiki K, Kashiwagi A, Masada M, Okamura T.

J Pharmacol Sci. 2004 Dec;96(4):401-5. Epub 2004 Dec 15. Review.

25.

Drug interaction between St John's Wort and quazepam.

Kawaguchi A, Ohmori M, Tsuruoka S, Nishiki K, Harada K, Miyamori I, Yano R, Nakamura T, Masada M, Fujimura A.

Br J Clin Pharmacol. 2004 Oct;58(4):403-10.

26.

Molecular mechanisms of impaired endothelial function associated with insulin resistance.

Shinozaki K, Kashiwagi A, Masada M, Okamura T.

Curr Drug Targets Cardiovasc Haematol Disord. 2004 Mar;4(1):1-11. Review.

PMID:
15032648
27.

Interindividual variation in the ratio between plasma morphine and its metabolites in cancer patients.

Tateishi M, Ohashi K, Kobayashi K, Hashimoto T, Yamaguchi J, Fujioka H, Izawa K, Masada M.

Int J Clin Pharmacol Res. 2003;23(2-3):75-82.

PMID:
15018021
28.

Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy.

Hirota T, Ieiri I, Takane H, Sano H, Kawamoto K, Aono H, Yamasaki A, Takeuchi H, Masada M, Shimizu E, Higuchi S, Otsubo K.

Drug Metab Dispos. 2003 May;31(5):677-80.

PMID:
12695358
29.

Stress and vascular responses: oxidative stress and endothelial dysfunction in the insulin-resistant state.

Shinozaki K, Kashiwagi A, Masada M, Okamura T.

J Pharmacol Sci. 2003 Mar;91(3):187-91. Review.

30.

Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice.

Ozaki M, Kawashima S, Yamashita T, Hirase T, Namiki M, Inoue N, Hirata K, Yasui H, Sakurai H, Yoshida Y, Masada M, Yokoyama M.

J Clin Invest. 2002 Aug;110(3):331-40.

31.

Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin.

Sugimoto K, Ohmori M, Tsuruoka S, Nishiki K, Kawaguchi A, Harada K, Arakawa M, Sakamoto K, Masada M, Miyamori I, Fujimura A.

Clin Pharmacol Ther. 2001 Dec;70(6):518-24.

PMID:
11753267
32.

Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress.

Shinozaki K, Hirayama A, Nishio Y, Yoshida Y, Ohtani T, Okamura T, Masada M, Kikkawa R, Kodama K, Kashiwagi A.

J Am Coll Cardiol. 2001 Dec;38(7):1821-8.

33.

Close correlation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate, an intracellular active metabolite, to the therapeutic efficacy of N(4)-behenoyl-1-beta-D-arabinofuranosylcytosine therapy for acute myelogenous leukemia.

Yamauchi T, Kawai Y, Goto N, Kishi S, Imamura S, Yoshida A, Urasaki Y, Fukushima T, Iwasaki H, Tsutani H, Masada M, Ueda T.

Jpn J Cancer Res. 2001 Sep;92(9):975-82.

34.

Monitoring of intracellular 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in 1-beta-D-arabinofuranosylcytosine therapy at low and conventional doses.

Yamauchi T, Kawai Y, Kishi S, Goto N, Urasaki Y, Imamura S, Fukushima T, Yoshida A, Iwasaki H, Tsutani H, Masada M, Ueda T.

Jpn J Cancer Res. 2001 May;92(5):546-53.

35.
36.

Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats.

Shinozaki K, Nishio Y, Okamura T, Yoshida Y, Maegawa H, Kojima H, Masada M, Toda N, Kikkawa R, Kashiwagi A.

Circ Res. 2000 Sep 29;87(7):566-73.

PMID:
11009561
37.
38.

Comedo-like acantholytic dyskeratosis of the face and scalp: a new entity?

Nakagawa T, Masada M, Moriue T, Takaiwa T.

Br J Dermatol. 2000 May;142(5):1047-8. No abstract available.

PMID:
10809872
39.

Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin-resistant rat aorta.

Shinozaki K, Kashiwagi A, Nishio Y, Okamura T, Yoshida Y, Masada M, Toda N, Kikkawa R.

Diabetes. 1999 Dec;48(12):2437-45.

PMID:
10580434
40.

A modified fluorescence polarization immunoassay method incorporating fat emulsion (FE-FPIA) to determine cyclosporin A concentrations in rat skin.

Kurosaki Y, Asada T, Yasumoto N, Nakamura T, Masada M, Kawasaki H.

Biol Pharm Bull. 1999 May;22(5):539-42.

PMID:
10375179
41.

Complexes of serine acetyltransferase and isozymes of cysteine synthase in spinach leaves.

Zhu X, Yamaguchi T, Masada M.

Biosci Biotechnol Biochem. 1998 May;62(5):947-52.

42.

Clinical pharmacology of intermediate and low-dose cytosine arabinoside (ara-C) therapy in patients with hematologic malignancies.

Ueda T, Matsuyama S, Yamauchi T, Kishi S, Fukushima T, Tsutani H, Nakamura T, Gotoh N, Masada M.

Adv Exp Med Biol. 1998;431:647-51. No abstract available.

PMID:
9598145
43.

Purification and characterization of a novel cysteine synthase isozyme from spinach hydrated seeds.

Yamaguchi T, Zhu X, Masada M.

Biosci Biotechnol Biochem. 1998 Mar;62(3):501-7.

44.

[Bayesian forecasting of plasma vancomycin concentration using time-dependent pharmacokinetics].

Nakamura T, Wakaki N, Kimura Y, Goto N, Masada M.

Yakugaku Zasshi. 1996 Nov;116(11):876-83. Japanese.

PMID:
8981831
45.

Comparative studies on cysteine synthase isozymes from spinach leaves.

Yamaguchi T, Masada M.

Biochim Biophys Acta. 1995 Sep 6;1251(2):91-8.

PMID:
7669816
46.

Improvement of the rectal bioavailability of latamoxef sodium by adjuvants following administration of a suppository.

Nakanishi K, Masukawa T, Masada M, Nadai T.

Biol Pharm Bull. 1994 Nov;17(11):1496-500.

PMID:
7703971
47.

Raman-scattering study of R2CuO4 (R=Pr, Nd, Sm, and Gd).

Udagawa M, Nagaoka Y, Ogita N, Masada M, Akimitsu J, Ohbayashi K.

Phys Rev B Condens Matter. 1994 Jan 1;49(1):585-588. No abstract available.

PMID:
10009320
48.

Gingival fluid IL-1 beta and IL-6 levels in menopause.

Reinhardt RA, Masada MP, Payne JB, Allison AC, DuBois LM.

J Clin Periodontol. 1994 Jan;21(1):22-5.

PMID:
8126239
49.

Determination of human immunoglobulin A and secretory immunoglobulin A in bronchoalveolar lavage fluids by solid phase enzyme immunoassay.

Sato T, Kitajima A, Ohmoto S, Chikuma M, Kado M, Nagai S, Izumi T, Takeyama M, Masada M.

Clin Chim Acta. 1993 Nov 15;220(2):145-56.

PMID:
8111959
50.

Gingival crevicular fluid IL-8: correlation with local IL-1 beta levels and patient estrogen status.

Payne JB, Reinhardt RA, Masada MP, DuBois LM, Allison AC.

J Periodontal Res. 1993 Nov;28(6 Pt 1):451-3.

PMID:
8254463

Supplemental Content

Loading ...
Support Center